G
G G Schwartz
Researcher at University of Colorado Denver
Publications - 3
Citations - 46
G G Schwartz is an academic researcher from University of Colorado Denver. The author has contributed to research in topics: Alirocumab & Medicine. The author has an hindex of 1, co-authored 1 publications receiving 13 citations.
Papers
More filters
Journal ArticleDOI
Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials
Christina Reith,Colin Baigent,L Blackwell,Jonathan Emberson,Enti Spata,Kelly Davies,Heather Halls,Lisa Holland,Kate Wilson,Jane Armitage,Charlie H.S. Harper,David Preiss,Alistair J. Roddick,Anthony C Keech,John Simes,Rory Collins,Elizabeth H Barnes,Jordan Fulcher,William G. Herrington,Adrienne Kirby,Borislava Mihaylova,Rachel O'Connell,Pierre Amarenco,Philip J. Barter,D. J. Betteridge (deceased),Michael A. Blazing,Jackie Bosch,Louise Bowman,Eugene Braunwald,Christopher P. Cannon,Michael Clearfield,Stuart M. Cobbe,Helen M. Colhoun,Björn Dahlöf,Barry Davis,James L. de Lemos,John R. Downs,Paul N. Durrington,Bengt Fellström,Ian Ford,MariaGrazia Franzosi,John Fuller (deceased),Curt D. Furberg,Robert J. Glynn,David Gordon,A. Gotto Jr.,Richard Grimm,Ajay Gupta,C. Morton Hawkins,Graham A. Hitman,Hallvard Holdaas (deceased),A.D Jardine,J. Wouter Jukema,John J.P. Kastelein,Sharon Kean,John Kjekshus,Genell Knatterud (deceased),Robert H Knopp (deceased),Wolfgang Koenig,M. Koren,Vera Krane,Martin J Landray,John C. LaRosa,Roberto Latini,Eva Lonn,Donata Lucci,Jean G. MacFadyen,Peter W. Macfarlane,Stephen MacMahon,Aldo P. Maggioni,Roberto Marchioli,Ian C. Marschner,Lemuel A. Moyé,Sabina A. Murphy,Andrew Neil,Enrico Nicolis,Chris J. Pickard,Sarah Parish,Terje R. Pedersen,Richard Peto,Marc A. Pfeffer,Neil R Poulter,Sara L. Pressel,Jeffrey L. Probstfield,Mahboob Rahman,Paul M. Ridker,Michele Robertson,F K Sacks,Naveed Sattar,Roland E. Schmieder,Patrick W. Serruys,Peter S. Sever,John Shaw (deceased),James Shepherd (deceased),Lara M. Simpson,Peter Sleight (deceased),Luigi Tavazzi,Gianni Tognoni,Andrew Tonkin,Stella Trompet,Christoph Wanner,Hans Wedel,Stephen E. Weis,K.M.A. Welch,Harvey Edward White Jr.,John Wikstrand,Lars Wilhelmsen,Stephen D. Wiviott,Robin Young,Salim Yusuf,Faiez Zannad,Hiroyuki Arashi,Robert P. Byington,Robert Clarke,Marcus Flather,Uri Goldbourt,S. Goto,Jemma C. Hopewell,Kees Hovingh,Patricia M. Kearney,George D. Kitas,Connie B. Newman,Marc S. Sabatine,G G Schwartz,Liam Smeeth,Jonathan A. Tobert,John Varigos,Junichi Yamaguchi +127 more
TL;DR: An individual participant data meta-analysis of all recorded adverse muscle events in large, long-term, randomised, double-blind trials of statin therapy found a small, clinically insignificant increase in median creatine kinase values of approximately 0·02 times the upper limit of normal.
Journal ArticleDOI
Cardiovascular Outcomes With Alirocumab After Acute Coronary Syndrome: Results of the Odyssey Outcomes Trial
Harvey D. White,Phillippe Gabriel Steg,M. Szarek,Deepak L. Bhatt,Vera Bittner,Rafael Diaz,J. Edelberg,Shaun G. Goodman,C. Hantoin,Robert A. Harrington,Johan Wouter Jukema,G. Lecorps,A. Moryusef,R. Pordy,M. Roe,Andreas M. Zeiher,G G Schwartz +16 more
Journal ArticleDOI
Longer-term safety of alirocumab with 24,610 patient-years of placebo-controlled observation: further insights from the ODYSSEY OUTCOMES trial
Shelly Goodman,P. Gabriel Steg,Michael Szarek,D. L. Bhatt,Vera Bittner,Rafael Diaz,Rachel Harrington,J. Wouter Jukema,Harvey D. White,A. M. Zeiher,Garen Manvelian,Y A Poulouin,Michel Scemama,W. Stipek,G G Schwartz +14 more
TL;DR: Alirocumab appears to be both a safe and effective lipid-modifying treatment when used for up to 5 yrs, and significantly reduced MACE vs. placebo, as previously reported.